Clinical Response of Convalescent Plasma Therapy in COVID-19 Patients in Dr. Saiful Anwar General Hospital
Author(s) -
Niniek Budiarti Burhan,
Herwindo Pudjo Brahmantyo,
Djoko Heri Hermanto,
Putu Moda Arsana
Publication year - 2021
Publication title -
jurnal kedokteran brawijaya
Language(s) - English
Resource type - Journals
ISSN - 2338-0772
DOI - 10.21776/ub.jkb.2021.031.04.5
Subject(s) - convalescent plasma , medicine , covid-19 , observational study , convalescence , intensive care medicine , disease , infectious disease (medical specialty)
The use of convalescent plasma has been beneficial for more than a century to treat various infections. The lack of effective treatment currently available for COVID-19 has reemerged the use of convalescent plasma as a potential therapeutic option. This is an observational descriptive study in 13 COVID-19 patient who got convalescent Plasma. Consist of 11 (84%) male patient, 2 (16%) female patient. Divided into two groups based on severity, and outcome. 38% patient included in severe disesase and 62% patient in critically Ill condition. 30% patient who got convalescent plasma deceased, and 70% had a resolve condition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom